Skip to main content
رجوع
Watch Compare

Odyssey Health, Inc.

جودة البيانات: 83%
ODYY
OTC Manufacturing Measuring & Analyzing Instruments
KWD 0.07
▼ KWD 0.00 (-5.26%)
6 months return
—
Momentum
Neutral
Free cash flow
-620,457.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-1.23

التقييم

PE (TTM)
-1.41
أعلى من متوسط القطاع (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -620,457.0

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -4.59 M
ROE N/A ROA -1061.07%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -620,457.0
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.06
Debt / Equity N/A Current Ratio 0.06
Interest Coverage -1.23 Asset Turnover N/A
Working Capital -10.60 M Tangible Book Value -10.60 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1.41 · EV/EBITDA: N/A
P/E Ratio -1.41 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9.56%
Market Cap 6.49 M Enterprise Value 6.49 M

Per Share

EPS: -0.05 · FCF/Share: -0.01
EPS (Diluted TTM) -0.05 Revenue / Share N/A
FCF / Share -0.01 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 13.52% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 13.52%
SBC-Adj. FCF -692,725 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0.0
Net Income -1.74 M -842,316.0 -5.92 M -8.44 M -16.88 M
EPS (Diluted) -0.02 -0.01 -0.07 -0.09 —
Gross Profit — — — — 0.0
Operating Income -1.02 M 14.26 M -5.31 M -8.11 M -15.86 M
EBITDA — — — — —
R&D Expenses 0.0 — — — 1.63 M
SG&A Expenses — — — — —
D&A — 1,538.0 3,416.0 2,374.0 5,552.0
Interest Expense 252,516.0 518,476.0 614,083.0 836,294.0 1.07 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 49,723.0 586,146.0 455,793.0 569,677.0 610,533.0
Total Liabilities — — — — 3.38 M
Shareholders' Equity -6.95 M -5.33 M -6.16 M -4.64 M -2.77 M
Total Debt — — — — 0.0
Cash & Equivalents — — 36,865.0 72,534.0 556,584.0
Current Assets 49,723.0 56,943.0 405,888.0 526,417.0 610,119.0
Current Liabilities 7.00 M 5.92 M 6.61 M 5.21 M 3.38 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -1.4 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3